Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testis cancer: the way forward.

D Raghavan1

  • 1Department of Clinical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Progress in Clinical and Biological Research
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AN UNUSUAL FOREIGN BODY IN THE BRONCHUS.

Medical journal, Armed Forces India·2016
Same author

GIANT EPIDERMOID CYST OF THE FLOOR OF MOUTH.

Medical journal, Armed Forces India·2016
Same author

Adjuvant chemotherapy for bladder cancer-why does level 1 evidence not support it?

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

3-[1-(4-Bromo-phen-yl)eth-oxy]-2,2,5-trimethyl-4-phenyl-3-aza-hexa-ne.

Acta crystallographica. Section E, Structure reports online·2014
Same author

Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.

Diabetes, obesity & metabolism·2013
Same author

A structured approach to uncommon cancers: what should a clinician do?

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same journal

DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.

Progress in clinical and biological research·2018
Same journal

Endotoxin and sepsis: molecular mechanisms of pathogenesis, host resistance, and therapy. Proceedings of the 4th Conference of the International Endotoxin Society. Nagoya, Japan, October 23-27, 1996.

Progress in clinical and biological research·1998
Same journal

The pathogenic role of LBP in gram-negative sepsis and septic shock.

Progress in clinical and biological research·1998
Same journal

The role of interleukin 6 in endotoxin-induced inflammatory responses.

Progress in clinical and biological research·1998
Same journal

Role of nitric oxide and reactive oxygen species in endotoxin shock.

Progress in clinical and biological research·1998
Same journal

Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.

Progress in clinical and biological research·1998
See all related articles

Testicular cancer management has advanced, making it highly curable. Focus now shifts to reducing treatment side effects while ensuring patient cure through specialized care.

Area of Science:

  • Oncology
  • Urology

Background:

  • Testicular cancer was a leading cause of cancer death in young men.
  • Recent advancements have significantly improved cure rates for testicular cancer.

Purpose of the Study:

  • To review the evolution of testicular cancer management over the past decade.
  • To emphasize the importance of reducing treatment side effects while maintaining cure rates.
  • To advocate for specialized care in dedicated centers for testicular cancer patients.

Main Methods:

  • Review of recent clinical advancements in testicular cancer treatment.
  • Analysis of changes in surgical protocols and chemotherapy regimens.
  • Discussion of potential risks associated with poorly evaluated clinical programs.

Related Experiment Videos

Main Results:

  • Testicular cancer has transitioned from a highly fatal disease to a curable one.
  • Treatment strategies are being refined to minimize side effects.
  • Potential risks exist from inadequately trained clinicians and unevaluated programs.

Conclusions:

  • Continued progress in testicular cancer management focuses on cure and reduced morbidity.
  • Specialized centers and experienced clinicians are crucial for optimal patient outcomes.
  • Caution is advised to prevent compromising cure rates through unproven methods.